Related Experiment Video
Updated: Jul 16, 2026

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
Structural basis of cooperative neutralization of the PldB toxin by immunity proteins in Pseudomonas aeruginosa
Xiaoyun Yang1, Jiawen Yang1, Hong Wang1,2
1Department of Pharmacology, SUSTech Homeostatic Medicine Institute, School of Medicine, Institute for Biological Electron Microscopy, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Abstract:
PldB, a type VI secretion system-dependent phospholipase D (PLD) effector secreted by multidrug-resistant Pseudomonas aeruginosa, alters host cell membrane permeability and facilitates pathogen internalization. Its cytotoxic activity is neutralized by three cognate immunity proteins-PA5086, PA5087, and PA5088-which protect the bacterium from self-intoxication. However, the underlying mechanism remains unclear. Through quantitative and qualitative analyses, we demonstrate that these three immunity proteins function cooperatively to inhibit PldB toxicity. Cryogenic electron microscopy of the PldB-PA5088 complex reveals that PA5088 binds to the HKD2 domain of PldB primarily through electrostatic interactions, markedly reducing the volume of its active center. Interaction studies using domain‑specific truncated PldB variants, together with enzyme activity assays, identify distinct copy numbers and binding regions for PA5086, PA5087, and PA5088 in their association with PldB. Collectively, our findings provide mechanistic insights into immunity protein-mediated neutralization of PldB toxicity, offering a potential foundation for designing PLD-targeting therapeutics against P. aeruginosa infection.
Insights
Multidrug-resistant Pseudomonas aeruginosa uses phospholipase D (PldB) to harm host cells. Three immunity proteins (PA5086, PA5087, PA5088) cooperatively neutralize PldB toxicity by blocking its active site.
Area of Science:
- Microbiology
- Structural Biology
- Biochemistry
Background:
- Pseudomonas aeruginosa is a multidrug-resistant pathogen.
- Type VI secretion systems (T6SS) deliver effector proteins into host cells.
- Phospholipase D (PLD) effectors like PldB disrupt host cell membranes.
Purpose of the Study:
- To elucidate the mechanism by which immunity proteins PA5086, PA5087, and PA5088 neutralize PldB toxicity.
- To understand the structural basis of PldB-immunity protein interactions.
Main Methods:
- Quantitative and qualitative analyses of protein interactions.
- Cryogenic electron microscopy (Cryo-EM) of the PldB-PA5088 complex.
- Enzyme activity assays and domain-specific truncation studies.
Main Results:
- PA5086, PA5087, and PA5088 cooperatively inhibit PldB cytotoxicity.
- PA5088 binds to the HKD2 domain of PldB via electrostatic interactions, obstructing the active site.
- Distinct binding regions and copy numbers for each immunity protein were identified.
Conclusions:
- The study provides mechanistic insights into PldB neutralization by cognate immunity proteins.
- This understanding can inform the development of novel therapeutics targeting PldB in P. aeruginosa infections.
More Related Videos
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Regulation of Bacterial Virulence
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Formation of Lipopolysaccharides
Bacterial Toxins

